Interscope Announces FDA De Novo Marketing Authorization of the EndoRotor® System for Direct Endoscopic Necrosectomy (DEN) ...Middle East

NORTHBRIDGE, Mass., Dec. 24, 2020 /PRNewswire/ -- Interscope, Inc. announced today the receipt of FDA de novo clearance to market its EndoRotor® System in the United States for direct endoscopic necrosectomy (DEN), a minimally invasive treatment for walled-off pancreatic necrosis. The...

Hence then, the article about interscope announces fda de novo marketing authorization of the endorotor system for direct endoscopic necrosectomy den was published today ( Thursday 24/12/2020 - 05:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Interscope Announces FDA De Novo Marketing Authorization of the EndoRotor® System for Direct Endoscopic Necrosectomy (DEN) )

Also on site :

• The memory chip crunch is paying off for this U.S. company
• Amazon's 'Lovely' $96 Foldable Acacia Bench Is Giving 'Charming' Storybook Cottage Energy
• Europe is pushing back on Washington’s chip war